Thromboprophylaxis and Bariatric Surgery

• Status: Unknown status
• Trial end date: 2012-12-01
• Target enrollment: 0
• Participant gender: All

Summary

This trial is an assessment of the efficacy of three thromboprophylaxis regimens in two types of bariatric surgery.

• gastric banding and gastric bypass on anti-Xa activity levels

The study includes two groups of 150 patients scheduled for gastric banding or gastric bypass.

Assessment of anti-Xa levels before and 4 hours after the injections from day 0 to 2 in order to determine the best prophylactic regimen allowing expected values ranged between 0.3 and 0.5 IU / ml.

• Phase: Phase 4
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: University Hospital, Strasbourg, France
• Collaborators: French State; Sanofi
• Treatments: Enoxaparin

Criteria

Inclusion Criteria:

• BMI over 40

• Gastric banding or gastric bypass

Exclusion Criteria:

• Renal insufficiency

• Thrombopenia

• Long term anticoagulant treatment

• Pregnancy

• Allergy to heparin